The SNORD91A and SLC40A1 as the exosome-associated molecules could impact the prognosis of ESCC and the recruitment of local M2 macrophage, possibly serving as the therapeutic targets for ESCC. This evidence concerns the gene SLC40A1 and esophageal squamous cell carcinoma.